NDC 67787-310 - HydrALAZINE Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67787-310
- Package NDCs from labels
- 67787-310-01, 67787-310-10
- Manufacturer
- InvaGen Pharmaceuticals, Inc.,
- Effective date
- 2008-12-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HydrALAZINE Hydrochloride - InvaGen Pharmaceuticals, Inc., | InvaGen Pharmaceuticals, Inc., | 2008-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67787-310-01 | HydrALAZINE Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 67787-310-10 | HydrALAZINE Hydrochloride | 1000 in 1 BOTTLE | TABLET | 1000 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Hydralazine Hydrochloride | ACTIVE INGREDIENT | FD171B778Y | HYDRALAZINE HYDROCHLORIDE TABLET [INVAGEN PHARMACEUTICALS, INC.,] | 1 | |
| Hydralazine | ACTIVE MOIETY | 26NAK24LS8 | HYDRALAZINE HYDROCHLORIDE TABLET [INVAGEN PHARMACEUTICALS, INC.,] | 1 | |
| FD&C Yellow # 6 | INACTIVE INGREDIENT | HYDRALAZINE HYDROCHLORIDE TABLET [INVAGEN PHARMACEUTICALS, INC.,] | 1 | ||
| Lactose anhydrous | INACTIVE INGREDIENT | HYDRALAZINE HYDROCHLORIDE TABLET [INVAGEN PHARMACEUTICALS, INC.,] | 1 | ||
| Microcrystalline cellulose | INACTIVE INGREDIENT | OP1R32D61U | HYDRALAZINE HYDROCHLORIDE TABLET [INVAGEN PHARMACEUTICALS, INC.,] | 1 | |
| Sodium starch glycolate | INACTIVE INGREDIENT | HYDRALAZINE HYDROCHLORIDE TABLET [INVAGEN PHARMACEUTICALS, INC.,] | 1 | ||
| Stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | HYDRALAZINE HYDROCHLORIDE TABLET [INVAGEN PHARMACEUTICALS, INC.,] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | ScieGen Pharmaceuticals, Inc. | 500b7f76-5f4e-4e7d-85c3-18b9f66d7504 | 2021-03-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Exelan Pharmaceuticals Inc. | 811831f9-a844-463a-874d-fb8407659f0b | 2020-09-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 63f388e0-9f3d-4902-990c-9a105aa098ad | 2020-09-01 | Warnings, Adverse reactions | 905225 |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | dfd60a79-2a30-41e6-b000-a144730099a8 | 2019-10-01 | Warnings, Adverse reactions | 905395 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 48cf71dd-19dc-4239-9117-ebcf9731a45d | 2019-10-01 | Warnings, Adverse reactions | 905199 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Ascend Laboratories, LLC | e7bfec3d-5222-4a26-8f99-6c2a28e14aa6 | 2017-12-28 | Warnings, Adverse reactions | 905225 905199 905395 905222 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | bfbd5960-ae6b-46f5-adfa-e330d7a21dfa | 2017-12-21 | Warnings, Adverse reactions | 905225 |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 921c8693-84c2-4313-a2a6-ab3be637d554 | 2016-07-14 | Warnings, Adverse reactions | 905222 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d9892176-d4a6-4edb-92b9-5f56243f3d22 | 2016-06-13 | Warnings, Adverse reactions | 905222 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ddbbdb09-3202-42d7-bbb0-08331dde2f54 | 2016-02-29 | Warnings, Adverse reactions | 905225 905199 905395 905222 |
| D668A6F7-F85D-AEA6-45EF-C0FA8AE3AFF0 | d8c6a541-1e02-48c9-92f2-cc850a0c12da | 2008-12-22 | Warnings, Adverse reactions | D668A6F7-F85D-AEA6-45EF-C0FA8AE3AFF0 d8c6a541-1e02-48c9-92f2-cc850a0c12da |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.